Balance Sheet for Cannabics Pharmaceuticals Inc (CNBX)

$ 0.209   -0.011 (-5.00%) Volume: 16.41k 3:33 PM EDT 18-Oct-2019
Statement: View:
Assets [+] in Thousands of Dollars
08/2018 08/2017 08/2016 08/2015 08/2014
Cash and Equivalents 1,394 3,368 19 25 99
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable - - 265 - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - 265 - -
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 227 150 3 0 14
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 1,621 3,517 22 26 113
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment 1,063 127 3 5 2
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 1,063 127 3 5 2
Gross Fixed Assets 1,063 127 3 5 2
Accumulated Depreciation (88) (7) (2) (1) (0)
Net Fixed Assets 974 120 2 3 1
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - - - -
Total Non-Current Assets 1,564 120 2 3 1
Total Assets 3,185 3,638 24 29 114
Liabilities [+] in Thousands of Dollars
08/2018 08/2017 08/2016 08/2015 08/2014
Accounts Payable 539 633 490 338 74
Short Term Debt - - - - -
Notes Payable - - 34 - -
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - - 50 - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities - 66 (83) - -
Total Current Liabilities 539 699 491 338 74
Long Term Debt N/A N/A N/A N/A N/A
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - 0 - -
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities - - 0 - -
Total Liabilities 539 699 491 338 74
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 2,646 2,939 (467) (310) 40
Common Par 12 12 11 10 10
Additional Paid in Capital 9,840 6,447 1,108 959 768
Cumulative Translation Adjustments - - - - -
Retained Earnings (7,297) (3,520) (1,586) (1,279) (738)
Treasury Stock - - - - -
Other Equity Adjustments - - - 33 -
Total Capitalization 2,646 2,939 (467) (310) 40
Total Equity 2,646 2,939 (467) (310) 40
Total Liabilities & Shareholder's Equity 3,185 3,638 24 29 114
Cash Flow (3,777) (1,934) (298) (543) (270)
Working Capital 1,081 2,818 (469) (313) 39
Free Cash Flow (2,917) (989) (120) (182) (227)
Invested Capital 2,646 2,939 (467) (310) 40
Shares Outstanding - Common Class Only 121,575 119,545 107,222 101,503 100,250
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 121,575 119,545 107,222 101,503 100,250
Total Common Shares Outstanding 121,575 119,545 107,222 101,503 100,250
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 120,378 110,380 103,258 100,707 51,632
Diluted Weighted Shares Outstanding 120,378 110,380 103,258 100,707 51,632